Browse Pet Safety Reports
16,698 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 16,698 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 16,698 FDA veterinary adverse event reports for Human.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Apr 30, 2019 | Human | Unknown | Selamectin | Application site tingling; Application site reaction NOS; Localised rash; Dia... | Outcome Unknown |
| Apr 30, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Product problem; Product Defect, General; A... | Ongoing |
| Apr 30, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Closure, Abnormal; Dispenser, Abnormal; Tub... | Recovered/Normal |
| Apr 28, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Recovered/Normal |
| Apr 27, 2019 | Human | Unknown | Oclacitinib Maleate | Accidental exposure; Mental impairment NOS | Outcome Unknown |
| Apr 26, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Accidental exposure; Expired drug administe... | Recovered/Normal |
| Apr 26, 2019 | Human | Unknown | Enrofloxacin | Headache; Disoriented state; Nausea | Outcome Unknown |
| Apr 25, 2019 | Human | Unknown | Enrofloxacin | Injection site lesion; Immediate pain upon injection; Injection site bleeding | Recovered/Normal |
| Apr 24, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Medication error; Difficulty of Use; Accide... | Recovered/Normal |
| Apr 23, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Medication error; Application site skin change NOS; Headache; Containers, Lea... | Ongoing |
| Apr 22, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Pruritus; Rash; Peeling skin; Sleepiness - systemic disorder | Ongoing |
| Apr 22, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Pruritus; Hives (see also 'Skin'); Rash; Sleepiness - systemic disorder | Ongoing |
| Apr 20, 2019 | Human | Unknown | Selamectin | Periorbital oedema | Outcome Unknown |
| Apr 19, 2019 | Human | Unknown | Moxidectin | Hyperthermia; General pain (see other SOCs for specific pain); Diarrhoea | Recovered/Normal |
| Apr 19, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Medication error; Application site skin change NOS; Closure, Abnormal; Contai... | Ongoing |
| Apr 19, 2019 | Human | Unknown | Imidacloprid; Moxidectin | Application site erythema | Recovered/Normal |
| Apr 19, 2019 | Human | Unknown | Tulathromycin | Puncture wound | Outcome Unknown |
| Apr 17, 2019 | Human | Unknown | Selamectin | Eye irritation; Eye pain | Outcome Unknown |
| Apr 17, 2019 | Human | Unknown | Praziquantel; Emodepside | Diarrhoea | Recovered/Normal |
| Apr 16, 2019 | Human | Unknown | Oclacitinib Maleate | Headache; Diarrhoea; High blood pressure; Accidental exposure | Outcome Unknown |
| Apr 16, 2019 | Human | Unknown | Spinosad; Milbemycin Oxime | Dizziness | Recovered/Normal |
| Apr 15, 2019 | Human | Unknown | Phytosphingosine Hydrochloride | Application site irritation; Product problem; Odor, Abnormal | Outcome Unknown |
| Apr 14, 2019 | Human | Unknown | Tylosin | Injection site bleeding | Recovered/Normal |
| Apr 14, 2019 | Human | Unknown | Neomycin Sulfate; Thiabendazole; Dexa... | Ocular burn; Nausea; Eye disorder NOS (for photophobia see 'neurological') | Outcome Unknown |
| Apr 12, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Containers, Leaking | Ongoing |
| Apr 12, 2019 | Human | Unknown | Tilmicosin | Injection site bleeding; Trauma NOS; Accidental exposure | Recovered/Normal |
| Apr 12, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Application site tingling | Ongoing |
| Apr 11, 2019 | Human | Unknown | Tildipirosin Injectable | Injection site bleeding; Injection site reaction NOS | Outcome Unknown |
| Apr 11, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Difficulty of Use; Accidental exposure | Recovered/Normal |
| Apr 11, 2019 | Human | Unknown | Tulathromycin | Injection site reaction NOS; Injection site bleeding | Recovered/Normal |
| Apr 9, 2019 | Human | Unknown | Selamectin | Localised pain NOS (see other 'SOCs' for specific pain); Skin irritation | Recovered/Normal |
| Apr 9, 2019 | Human | Unknown | Phytosphingosine Salicyloyl; Chlorhex... | Eye irritation | Ongoing |
| Apr 9, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Application site burning sensation; Difficu... | Recovered/Normal |
| Apr 9, 2019 | Human | Unknown | Oclacitinib Maleate | Tingling sensation; Vomiting; Accidental exposure | Ongoing |
| Apr 9, 2019 | Human | Unknown | Eprinomectin | Dizziness; Fatigue; Vomiting; Diarrhoea; Bloodshot eye | Outcome Unknown |
| Apr 9, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Medication error; Application site reaction NOS; Dispenser, Abnormal; Difficu... | Recovered/Normal |
| Apr 8, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Medication error; Difficulty of Use; Patien... | Ongoing |
| Apr 7, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Medication error; Dispenser, Abnormal; Diff... | Recovered/Normal |
| Apr 5, 2019 | Human | Unknown | Insulin Injectable Vial | Injection site pain; Injection site paraesthesia; Injection site reaction NOS | Recovered/Normal |
| Apr 5, 2019 | Human | Unknown | Lotilaner | Hives (see also 'Skin'); Itching; Burning sensation (skin); Pinnal reddening;... | Outcome Unknown |
| Apr 5, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Accidental exposure | Recovered/Normal |
| Apr 5, 2019 | Human | Unknown | Moxidectin | Injection site pain; Systemic disorder NOS | Outcome Unknown |
| Apr 5, 2019 | Human | Unknown | Enrofloxacin | Injection site lesion; Injection site bleeding | Outcome Unknown |
| Apr 5, 2019 | Human | Unknown | Fenbendazol Suspension | Numbness; Stomach upset; Dizziness; Medication error | Outcome Unknown |
| Apr 4, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Vomiting; Abdominal pain | Ongoing |
| Apr 4, 2019 | Human | Unknown | Afoxolaner | Nasal discharge; Breathlessness | Outcome Unknown |
| Apr 4, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Emesis (multiple) | Outcome Unknown |
| Apr 4, 2019 | Human | Unknown | Tulathromycin | Puncture wound | Outcome Unknown |
| Apr 4, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Accidental exposure | Ongoing |
| Apr 4, 2019 | Human | Unknown | Ceftiofur Sodium | Ocular burn | Recovered/Normal |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.